New Joint Initiative For More Efficient, Adaptable Clinical Practice Guidelines

19/02/2019 David Branigan

Wellcome Trust, the Bill & Melinda Gates Foundation and the African Academy of Sciences have joined together in a new initiative to make clinical practice guidelines more efficient and adaptable for clinical trials that require less stringent approaches, such as those that take place during infectious disease outbreaks. Additionally, by applying a more flexible approach towards the application of these guidelines, the initiative also hopes to make them “future proof,” or able to better incorporate new technologies. Continue reading ->

‘Netflix’ Pricing Model Eases Australians’ Access To Expensive Hepatitis C Drugs

14/02/2019 Elaine Ruth Fletcher

An innovative five-year agreement between the Australian government and pharmaceutical companies, involving a lump sum payment of about US$ 766 million for an unlimited five-year supply of the most advanced Hepatitis C (HCV) drugs, has reduced the per-patient costs of these cutting-edge treatments by roughly 85%, according to a study today in the New England Journal of Medicine. Continue reading ->

Unitaid Calls For Proposals To Develop Technologies To Treat Malaria, HIV, TB

13/02/2019 David Branigan

Unitaid has launched two separate calls for proposals for the development of improved technologies to better diagnose and treat Plasmodium vivax malaria, and to more effectively treat HIV and its coinfections, including tuberculosis and malaria, in low and middle-income countries. Continue reading ->